1 completed, 1 terminated, 1 unknown. 3 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Terminated 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Terminated 1 |
Follow polysaccharide-K: new trials by email Literature Review of polysaccharide-K trials Research Report on polysaccharide-K
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vaccine Therapy With or Without Polysaccharide-K in Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody Therapy HER-2/neu Intracellular Domain Protein, Laboratory Biomarker Analysis, Pertuzumab - HER2/Neu Positive, Recurrent Breast Carcinoma | Phase 1 / Phase 2 | Completed | University of Washington | 31 | 2014-02-05 | 2023-04-18 |
| Feasibility Study of CDDP + CPT-11 + PSK for Extensive-Stage Disease (ED) Small Cell Lung Cancer Irinotecan hydrochloride, Cisplatin, Krestin - Small Cell Lung Cancer | Phase 2 | Unknown | University of Toyama | 45 | 2007-11-01 | 2008-09-03 |
| Phase II Study of TS-1 Therapy and TS-1+PSK Therapy Against Advanced Gastric Carcinoma Tegafur/gimeracil/oteracil potassium (S-1), Krestin (PSK), Tegafur/gimeracil/oteracil potassium (S-1) - Gastric Cancer | Phase 2 / Phase 3 | Terminated | Eastern Network of Cancer Immunological Therapy, Japan | 13 | 2006-10-01 | 2009-01-23 |
Breast Neoplasms (1) · Small Cell Lung Carcinoma (1) · Stomach Neoplasms (1)
Eastern Network of Cancer Immunological Therapy, Japan (1) · University of Toyama (1) · University of Washington (1)
Japan (2) · United States (1)
Hideaki Tahara, MD (1) · Lupe Salazar (1) · Tatsuhiko Kashii, MD, PhD (1)
P30CA015704 (1), U19AT006028 (1)